Kura Oncology (KURA) Free Cash Flow (2010 - 2026)
Kura Oncology (KURA) reported Free Cash Flow of -$86.0 million for Q1 2026, down 19.06% year-over-year from -$106.2 million in Q1 2025, and down 176.32% on a QoQ basis from $112.7 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Free Cash Flow data on file, last reported at -$86.0 million in Q1 2026.
- Quarterly Free Cash Flow fell 19.06% year-over-year to -$86.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$84.5 million (down 176.4% YoY) and the FY2025 annual result came in at -$70.7 million, down 152.82% from the prior year.
- Free Cash Flow fell to -$86.0 million in Q1 2026 per KURA's latest filing, from $112.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $268.8 million in Q4 2024 and bottomed at -$86.0 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$32.2 million (2022), against an average of -$15.2 million.
- The widest annual swing landed in 2024, when Free Cash Flow soared 883.01%; it then tumbled 86.24% in 2025.
- Tracing KURA's Free Cash Flow over 5 years: stood at -$26.5 million in 2022, then decreased by 29.32% to -$34.3 million in 2023, then soared by 883.01% to $268.8 million in 2024, then sank by 58.08% to $112.7 million in 2025, then slumped by 176.32% to -$86.0 million in 2026.
- Per Business Quant, the three latest KURA Free Cash Flow figures stand at -$86.0 million (Q1 2026), $112.7 million (Q4 2025), and -$80.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | -85.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.98 Mn |
| Mar 31, 2026 | -85.98 Mn |
| Dec 31, 2025 | 112.66 Mn |
| Dec 31, 2025 | 112.66 Mn |
| Sep 30, 2025 | -80.90 Mn |
| Sep 30, 2025 | -80.90 Mn |
| Jun 30, 2025 | -30.24 Mn |
| Jun 30, 2025 | -30.24 Mn |
| Mar 31, 2025 | -72.22 Mn |
| Mar 31, 2025 | -72.22 Mn |
| Dec 31, 2024 | 268.76 Mn |
| Dec 31, 2024 | 268.76 Mn |
| Sep 30, 2024 | -43.44 Mn |
| Sep 30, 2024 | -43.44 Mn |
| Jun 30, 2024 | -42.55 Mn |
| Jun 30, 2024 | -42.55 Mn |
| Mar 31, 2024 | -48.93 Mn |
| Mar 31, 2024 | -48.93 Mn |
| Dec 31, 2023 | -34.32 Mn |
| Dec 31, 2023 | -34.32 Mn |
| Sep 30, 2023 | -29.05 Mn |
| Sep 30, 2023 | -29.05 Mn |
| Jun 30, 2023 | -25.71 Mn |
| Jun 30, 2023 | -25.71 Mn |
| Mar 31, 2023 | -35.91 Mn |
| Mar 31, 2023 | -35.91 Mn |
| Dec 31, 2022 | -26.54 Mn |
| Dec 31, 2022 | -26.54 Mn |
| Sep 30, 2022 | -21.39 Mn |
| Sep 30, 2022 | -21.39 Mn |
| Jun 30, 2022 | -30.53 Mn |
| Jun 30, 2022 | -30.53 Mn |
| Mar 31, 2022 | -32.23 Mn |
| Mar 31, 2022 | -32.23 Mn |
| Dec 31, 2021 | -23.47 Mn |
| Dec 31, 2021 | -23.47 Mn |
| Sep 30, 2021 | -25.32 Mn |
| Sep 30, 2021 | -25.32 Mn |
| Jun 30, 2021 | -28.37 Mn |
| Jun 30, 2021 | -28.37 Mn |
| Mar 31, 2021 | -28.55 Mn |
| Mar 31, 2021 | -28.55 Mn |
| Dec 31, 2020 | -18.58 Mn |
| Dec 31, 2020 | -18.58 Mn |
| Sep 30, 2020 | -17.63 Mn |
| Sep 30, 2020 | -17.63 Mn |
| Jun 30, 2020 | -15.45 Mn |
| Jun 30, 2020 | -15.45 Mn |
| Mar 31, 2020 | -20.33 Mn |
| Mar 31, 2020 | -20.33 Mn |
| Dec 31, 2019 | -13.93 Mn |
| Dec 31, 2019 | -13.93 Mn |
| Sep 30, 2019 | -12.15 Mn |
| Sep 30, 2019 | -12.15 Mn |
| Jun 30, 2019 | -14.43 Mn |
| Jun 30, 2019 | -14.43 Mn |
| Mar 31, 2019 | -14.25 Mn |
| Mar 31, 2019 | -14.25 Mn |
| Dec 31, 2018 | -10.21 Mn |
| Dec 31, 2018 | -10.21 Mn |
| Sep 30, 2018 | -13.00 Mn |
| Sep 30, 2018 | -13.00 Mn |
| Jun 30, 2018 | -12.59 Mn |
| Jun 30, 2018 | -12.59 Mn |
| Mar 31, 2018 | -12.85 Mn |
| Mar 31, 2018 | -12.85 Mn |
| Dec 31, 2017 | -7.47 Mn |
| Dec 31, 2017 | -7.47 Mn |
| Sep 30, 2017 | -6.24 Mn |
| Sep 30, 2017 | -6.24 Mn |
| Jun 30, 2017 | -6.11 Mn |
| Jun 30, 2017 | -6.11 Mn |
| Mar 31, 2017 | -8.62 Mn |
| Mar 31, 2017 | -8.62 Mn |
| Dec 31, 2016 | -6.74 Mn |
| Dec 31, 2016 | -6.74 Mn |
| Sep 30, 2016 | -5.47 Mn |
| Sep 30, 2016 | -5.47 Mn |
| Jun 30, 2016 | -5.83 Mn |
| Jun 30, 2016 | -5.83 Mn |
| Mar 31, 2016 | -7.31 Mn |
| Mar 31, 2016 | -7.31 Mn |
| Dec 31, 2015 | -5.62 Mn |
| Dec 31, 2015 | -5.62 Mn |
| Sep 30, 2015 | -4.45 Mn |
| Sep 30, 2015 | -4.45 Mn |
| Jun 30, 2015 | -3.78 Mn |
| Jun 30, 2015 | -3.78 Mn |
| Mar 31, 2015 | -4.13 Mn |
| Mar 31, 2015 | -4.13 Mn |
| Dec 31, 2014 | -877,000.00 |
| Dec 31, 2014 | -877,000.00 |
| Sep 30, 2014 | -27,000.00 |
| Sep 30, 2014 | -27,000.00 |
| Jun 30, 2014 | -1,250.00 |
| Jun 30, 2014 | -1,250.00 |
| Mar 31, 2014 | -400.00 |
| Mar 31, 2014 | -400.00 |
| Dec 31, 2013 | -4,012.00 |
| Dec 31, 2013 | -4,012.00 |
| Sep 30, 2013 | -8,125.00 |
| Sep 30, 2013 | -8,125.00 |
| Jun 30, 2013 | -9,196.00 |
| Jun 30, 2013 | -9,196.00 |
| Mar 31, 2013 | -1,901.00 |
| Mar 31, 2013 | -1,901.00 |
| Dec 31, 2012 | -784.00 |
| Dec 31, 2012 | -784.00 |
| Sep 30, 2012 | -3,895.00 |
| Sep 30, 2012 | -3,895.00 |
| Jun 30, 2012 | -14,262.00 |
| Jun 30, 2012 | -14,262.00 |
| Mar 31, 2012 | -5,477.00 |
| Mar 31, 2012 | -5,477.00 |
| Dec 31, 2011 | -1,935.00 |
| Dec 31, 2011 | -1,935.00 |
| Sep 30, 2011 | -3,100.00 |
| Sep 30, 2011 | -3,100.00 |
| Jun 30, 2011 | -15,379.00 |
| Jun 30, 2011 | -15,379.00 |
| Mar 31, 2011 | -2,264.00 |
| Mar 31, 2011 | -2,264.00 |
| Dec 31, 2010 | -356.00 |
| Dec 31, 2010 | -356.00 |
| Sep 30, 2010 | -3,506.00 |
| Sep 30, 2010 | -3,506.00 |